Ken Griffin Charles River Laboratories International, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 45,000 shares of CRL stock, worth $7.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,000
Previous 56,900
20.91%
Holding current value
$7.7 Million
Previous $11.2 Million
25.88%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.05 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$870 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$697 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$373 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$309 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.7B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...